Skip to content

Treatment of involuntary leakage of urine after finishing urination with Unani medicine Majoon-e-Rashidi

Clinical validation of Majoon-e-Rashidi in Taqteer-ul-Baul (Post Micturition Dribble- PMD) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092352
Enrollment
180
Registered
2025-08-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N394- Other specified urinary incontinence

Interventions

Intervention1: Majoon-e-Rashidi: 5g (semisolid) to be taken orally twice a day with water after meal for 8 weeks Control Intervention1: NIL: NIL

Sponsors

Central Council for Research in Unani Medicine CCRUM New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group of 18-65 years 2. Either sex 3. Male patient with Grade 1 prostatomegaly 4. Subjects presenting with any of the following symptoms: i. Difficulty in urine ii. Pain during micturition iii. Passing of urine uncontrolled iv. Patient cannot hold urine for a long period and pass without sensation vi. Burning in the urethra or felling of hotness during micturition

Exclusion criteria

Exclusion criteria: 1. Serious or uncontrolled Cardiovascular, Hepatic or Respiratory Disease. 2. Male patient with Grade 2 & grade 3 prostatomegaly 3. Renal insufficiency and Malignancy 4. Serious or uncontrolled Diabetes 5. Chronic Tobacco chewing or Smoking 6. Alcoholism 7. Pregnant/Lactating women. 8. Allergy/Hypersensitivity to any ingredients of the drug.

Design outcomes

Primary

MeasureTime frame
The assessment of the efficacy will be done on the basis of the The Hallym post micturition dribbling questionnaire.Timepoint: At baseline, 14th, 28th, 42nd and 56th day

Secondary

MeasureTime frame
Haematological & biochemical assessment for safety assessment i.e. CBC, LFT, KFT, Urine Routine & microscopic examination.Timepoint: At baseline and after 8 weeks

Countries

India

Contacts

Public ContactDr Pradeep Kumar

Central Council for Research in Unani Medicine (CCRUM)

javed.ghazal@gmail.com9811810454

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026